FBR Capital Reiterates an 'Outperform' on Maiden Holdings (MHLD); Shares Up Nicely, but Material Upside Remains
Tweet
Share
E-mailGet Alerts MHLD Hot Sheet
Price: $1.15 --0%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
FBR Capital reiterates an 'Outperform' on Maiden Holdings (NASDAQ: MHLD), PT $11.
FBR analyst says, "Since the end of April, Maiden Holdings has outperformed all the relevant benchmarks by a considerable margin, as shares are up more than 19%. In comparison, the S&P 500 is down 2% over the same period. We view this strong performance as justified, and we believe that, despite the runup in the stock, a material amount of upside remains. Not only is the company performing well fundamentally, but there is also a potential catalyst in the form of debt refinancing."
For more ratings news on Maiden Holdings click here and for the rating history of Maiden Holdings click here.
Shares of Maiden Holdings closed at $8.89 yesterday.
FBR analyst says, "Since the end of April, Maiden Holdings has outperformed all the relevant benchmarks by a considerable margin, as shares are up more than 19%. In comparison, the S&P 500 is down 2% over the same period. We view this strong performance as justified, and we believe that, despite the runup in the stock, a material amount of upside remains. Not only is the company performing well fundamentally, but there is also a potential catalyst in the form of debt refinancing."
For more ratings news on Maiden Holdings click here and for the rating history of Maiden Holdings click here.
Shares of Maiden Holdings closed at $8.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- ADC Therapeutics (ADCT) PT Lowered to $5 at Guggenheim
- Agios Pharma (AGIO) Reiterated at Overweight by Cantor Fitzgerald on Thalassemia Opportunity
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
